Single-cell level assessment of a melanoma patient tumor microarray revealed a robust correlation of transcriptionally active AR, fucosylated L1CAM, and loss of cell-cell junction complexes with stage IIB-III tumors in male patients, consistent with the contribution of this signaling mechanism to augment invasive capacity required for early stages of the metastatic cascade. The gene discussed is L1CAM; the disease is melanoma.